Home › Companies › SOLENO THERAPEUTICS INC. › 2024-2025
At SOLENO THERAPEUTICS INC.'s shareholder meeting held June 5, 2025, in the 2024-2025 proxy season, 79 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 657 separate fund positions. On the most widely held item on that ballot — TO RATIFY THE APPOINTMENT OF CBIZ CPAS P.C. AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING… — SOLENO THERAPEUTICS INC.'s filing reports the proposal as approved, with 99.9% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: SOLENO THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and SOLENO THERAPEUTICS INC.’s Form 8-K, filed June 6, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 5, 2025: 3 items on SOLENO THERAPEUTICS INC.’s Form 8-K, filed June 6, 2025: 1 approved · 2 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025
Explore SOLENO THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are SOLENO THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Anish Bhatnagar | 42,591,113 | -- | -- | 3,565,411 | 1,117,442 | 92% | Not verified | — |
| Elect Director: William Harris | 32,331,183 | -- | -- | 13,825,341 | 1,117,442 | 70% | Not verified | — |
| 2. To ratify the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 47,253,371 | 8,580 | 12,015 | -- | 0 | 99.9% | Approved | — |
Source: SOLENO THERAPEUTICS INC., Form 8-K, filed with the SEC on June 6, 2025 — read the filing on EDGAR.
Each item below shows how the 79 asset managers that disclosed a SOLENO THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To elect two Class II directors to each serve until the 2028 Annual Meeting of stockholders or until his successor is duly elected and qualified: Anish Bhatnagar, M.D.
SOLENO THERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Anish Bhatnagar”): 42,591,113 for, 3,565,411 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 78 asset managers below reported 9,892,365 for, 2,706,172 withheld, 218,850 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 563,028 | 0 | 0 | 2,520,729 | Mixed |
| T. Rowe Price | 2,120,874 | 0 | 0 | 0 | For |
| Vanguard | 1,818,441 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,587,069 | 0 | 0 | 0 | For |
| State Street | 598,685 | 0 | 0 | 12 | For |
| BlackRock | 464,867 | 0 | 0 | 0 | For |
| Capital Group | 464,833 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 338,110 | 0 | 0 | 0 | For |
| BNY Mellon | 228,600 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 0 | 0 | 218,837 | 0 | Abstain |
| Charles Schwab | 215,810 | 0 | 0 | 0 | For |
| Invesco | 190,785 | 0 | 0 | 0 | For |
| Hartford | 145,971 | 0 | 0 | 0 | For |
| Principal | 178 | 0 | 0 | 131,711 | Withhold |
| Equitable | 81,023 | 0 | 0 | 0 | For |
| TIAA | 80,077 | 0 | 0 | 0 | For |
| MoA Funds Corp | 71,643 | 0 | 0 | 0 | For |
| Royce | 59,458 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,562 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 51,959 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 0 | 0 | 0 | 50,895 | Withhold |
| Allspring | 50,727 | 0 | 0 | 0 | For |
| Harbor Funds II | 49,218 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,031 | 0 | 0 | 0 | For |
| Northwestern Mutual | 38,043 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. All 78 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
Description as filed by funds: To elect two Class II directors to each serve until the 2028 Annual Meeting of stockholders or until his successor is duly elected and qualified: William G. Harris
SOLENO THERAPEUTICS INC.’s own tally for this item (“Elect Director: William Harris”): 32,331,183 for, 13,825,341 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 78 asset managers below reported 5,729,996 for, 5,945,185 withheld, 1,142,206 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 3,083,757 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 2,120,874 | Withhold |
| Vanguard | 1,818,441 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,587,069 | 0 | 0 | 0 | For |
| State Street | 587,774 | 0 | 0 | 10,923 | For |
| BlackRock | 0 | 0 | 464,867 | 0 | Abstain |
| Capital Group | 464,833 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 0 | 0 | 338,110 | 0 | Abstain |
| BNY Mellon | 228,600 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 0 | 0 | 218,837 | 0 | Abstain |
| Charles Schwab | 215,810 | 0 | 0 | 0 | For |
| Invesco | 190,785 | 0 | 0 | 0 | For |
| Hartford | 145,971 | 0 | 0 | 0 | For |
| Principal | 178 | 0 | 0 | 131,711 | Withhold |
| Equitable | 0 | 0 | 0 | 81,023 | Withhold |
| TIAA | 80,077 | 0 | 0 | 0 | For |
| MoA Funds Corp | 0 | 0 | 0 | 71,643 | Withhold |
| Royce | 59,458 | 0 | 0 | 0 | For |
| Prudential/PGIM | 49,485 | 0 | 0 | 3,077 | Mixed |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 51,959 | Withhold |
| RBB FUND, INC. | 0 | 0 | 0 | 50,895 | Withhold |
| Allspring | 0 | 0 | 0 | 50,727 | Withhold |
| Harbor Funds II | 49,218 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 44,031 | 0 | Abstain |
| Northwestern Mutual | 38,043 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. All 78 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF CBIZ CPAS P.C. AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
SOLENO THERAPEUTICS INC.’s own tally for this item (“2. To ratify the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 47,253,371 for, 8,580 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two - Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 by the following votes:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 79 asset managers below reported 12,818,862 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,083,757 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,120,874 | 0 | 0 | 0 | For |
| Vanguard | 1,818,441 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,587,069 | 0 | 0 | 0 | For |
| State Street | 598,697 | 0 | 0 | 0 | For |
| BlackRock | 464,867 | 0 | 0 | 0 | For |
| Capital Group | 464,833 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 338,110 | 0 | 0 | 0 | For |
| BNY Mellon | 228,600 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 218,837 | 0 | 0 | 0 | For |
| Charles Schwab | 215,810 | 0 | 0 | 0 | For |
| Invesco | 190,785 | 0 | 0 | 0 | For |
| Hartford | 145,971 | 0 | 0 | 0 | For |
| Principal | 131,889 | 0 | 0 | 0 | For |
| Equitable | 81,023 | 0 | 0 | 0 | For |
| TIAA | 80,077 | 0 | 0 | 0 | For |
| MoA Funds Corp | 71,643 | 0 | 0 | 0 | For |
| Royce | 59,458 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,562 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 51,959 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 50,895 | 0 | 0 | 0 | For |
| Allspring | 50,727 | 0 | 0 | 0 | For |
| Harbor Funds II | 49,218 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,031 | 0 | 0 | 0 | For |
| Northwestern Mutual | 38,043 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. All 79 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 50,393,931 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 6.12% |
| 2 | T. Rowe Price | 4.21% |
| 3 | Vanguard | 3.61% |
| 4 | JANUS INVESTMENT FUND | 3.15% |
| 5 | State Street | 1.19% |
| 6 | BlackRock | 0.92% |
| 7 | Capital Group | 0.92% |
| 8 | HARBOR FUNDS | 0.67% |
| 9 | BNY Mellon | 0.45% |
| 10 | FINANCIAL INVESTORS TRUST | 0.43% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RWC Asset Management LLP | 0.01% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities Associated with Janus Henderson | 10.30% | DEF14A |
| Entities Associated with Vivo Capital LLC | 8.85% | DEF14A |
| Entities Associated with Nantahala Capital Management | 8.63% | DEF14A |
| Entities Associated with Adage Capital Advisors, LLC | 5.51% | DEF14A |
| T. Rowe Price | 4.76% | 13F |
| Avoro Capital Advisors LLC | 4.56% | 13G |
| Vivo Opportunity Fund Holdings, L.P. | 4.47% | 13G |
| FMR (Fidelity) | 4.43% | 13F |
| Citadel Advisors | 4.12% | 13F |
| Andrew Sinclair | 3.97% | DEF14A |
Percentages above are of 50,393,931 shares outstanding, as reported by SOLENO THERAPEUTICS INC. on its Form 10-Q dated May 2, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SOLENO THERAPEUTICS INC.’s 10-Q dated May 2, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
SOLENO THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page).
proxyvotesnow.com, “SOLENO THERAPEUTICS INC. 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/soleno-therapeutics-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.